Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study

BACKGROUND: Hemodialysis patients are prone to constipation, which can adversely affect their quality of life (QOL). Elobixibat, a highly selective inhibitor of the ileal bile acid transporter, can increase the bile acid level in the colon and, subsequently, enhance colonic motility and secretion. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamei, Daigo, Kamei, Yuiko, Nagano, Masashi, Mineshima, Michio, Nitta, Kosaku, Tsuchiya, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995167/
https://www.ncbi.nlm.nih.gov/pubmed/32005162
http://dx.doi.org/10.1186/s12876-020-1179-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995167/
https://www.ncbi.nlm.nih.gov/pubmed/32005162
http://dx.doi.org/10.1186/s12876-020-1179-6

Ejemplares similares